These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 23714342)

  • 1. Emerging fungal infections in solid organ transplant recipients.
    Shoham S
    Infect Dis Clin North Am; 2013 Jun; 27(2):305-16. PubMed ID: 23714342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changing epidemiology of systemic fungal infections.
    Richardson M; Lass-Flörl C
    Clin Microbiol Infect; 2008 May; 14 Suppl 4():5-24. PubMed ID: 18430126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Invasive non-Aspergillus mold infections in transplant recipients, United States, 2001-2006.
    Park BJ; Pappas PG; Wannemuehler KA; Alexander BD; Anaissie EJ; Andes DR; Baddley JW; Brown JM; Brumble LM; Freifeld AG; Hadley S; Herwaldt L; Ito JI; Kauffman CA; Lyon GM; Marr KA; Morrison VA; Papanicolaou G; Patterson TF; Perl TM; Schuster MG; Walker R; Wingard JR; Walsh TJ; Kontoyiannis DP
    Emerg Infect Dis; 2011 Oct; 17(10):1855-64. PubMed ID: 22000355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mold Infections in Solid Organ Transplant Recipients.
    Lemonovich TL
    Infect Dis Clin North Am; 2018 Sep; 32(3):687-701. PubMed ID: 30146030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fungal infections in immunocompromised patients.
    Sganga G
    Mycoses; 2011 Dec; 54 Suppl 4():1-3. PubMed ID: 22126521
    [No Abstract]   [Full Text] [Related]  

  • 6. Trends in the epidemiology of opportunistic fungal infections: predisposing factors and the impact of antimicrobial use practices.
    Singh N
    Clin Infect Dis; 2001 Nov; 33(10):1692-6. PubMed ID: 11641825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of the 'Big Five' mold killers of humans: Aspergillus, Fusarium, Lomentospora, Scedosporium and Mucormycetes.
    Thornton CR
    Adv Appl Microbiol; 2020; 110():1-61. PubMed ID: 32386603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging and less common fungal pathogens.
    Fleming RV; Walsh TJ; Anaissie EJ
    Infect Dis Clin North Am; 2002 Dec; 16(4):915-33, vi-vii. PubMed ID: 12512187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Candidiasis, aspergillosis and other invasive mycoses in recipients of solid organ transplants].
    Quindós G
    Rev Iberoam Micol; 2011; 28(3):110-9. PubMed ID: 21700230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Current indications for voriconazole in onco-hematological patients].
    Jarque I; Sanz MA
    Rev Iberoam Micol; 2007 Sep; 24(3):213-6. PubMed ID: 17874858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fungal infections in nontransplant patients with hematologic malignancies.
    Segal BH; Bow EJ; Menichetti F
    Infect Dis Clin North Am; 2002 Dec; 16(4):935-64, vii. PubMed ID: 12512188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opportunistic mycelial fungal infections in organ transplant recipients: emerging importance of non-Aspergillus mycelial fungi.
    Husain S; Alexander BD; Munoz P; Avery RK; Houston S; Pruett T; Jacobs R; Dominguez EA; Tollemar JG; Baumgarten K; Yu CM; Wagener MM; Linden P; Kusne S; Singh N
    Clin Infect Dis; 2003 Jul; 37(2):221-9. PubMed ID: 12856215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breakthrough invasive fungal infections: Who is at risk?
    Jenks JD; Cornely OA; Chen SC; Thompson GR; Hoenigl M
    Mycoses; 2020 Oct; 63(10):1021-1032. PubMed ID: 32744334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Scedosporium apiospermum disseminated infection in a single lung transplant recipient].
    Solé A
    Rev Iberoam Micol; 2011; 28(3):139-42. PubMed ID: 21700235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in the management of opportunistic fungal infections.
    Sanchez JL; Noskin GA
    Compr Ther; 1996 Nov; 22(11):703-12. PubMed ID: 8978976
    [No Abstract]   [Full Text] [Related]  

  • 16. Opportunistic deep cutaneous mycoses in solid organ transplant recipients.
    Tessari G; Cagalli A; Girolomoni G
    G Ital Dermatol Venereol; 2014 Aug; 149(4):417-22. PubMed ID: 25068229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antifungal attributes of immunosuppressive agents: new paradigms in management and elucidating the pathophysiologic basis of opportunistic mycoses in organ transplant recipients.
    Singh N; Heitman J
    Transplantation; 2004 Mar; 77(6):795-800. PubMed ID: 15077015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fungal infections in the recipients of solid organ transplantation.
    Singh N
    Infect Dis Clin North Am; 2003 Mar; 17(1):113-34, viii. PubMed ID: 12751263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endemic Fungal Infection Recommendations for Solid-Organ Transplant Recipients and Donors.
    Abdala E; Miller R; Pasqualotto AC; Muñoz P; Colombo AL; Cuenca-Estrella M
    Transplantation; 2018 Feb; 102(2S Suppl 2):S52-S59. PubMed ID: 29381578
    [No Abstract]   [Full Text] [Related]  

  • 20. The emerging fungal threat.
    Sternberg S
    Science; 1994 Dec; 266(5191):1632-4. PubMed ID: 7702654
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.